France: Endocrine Disruptors - Senate Hearing and New Administration

  |   Attaché Report (GAIN)

In April 2017 the Commission of European Affairs of the French Senate organized a hearing on endocrine disruptors (EDs). The Commission said that France and the European Union (EU) should increase research to identify EDs and develop substitutes. In May 2017, Emmanuel Macron was elected President of France, and his position on the issue is similar to that of the previous administration although he noted during the campaign the importance of having clear information before instituting a ban on products without substitutes.  

France: Endocrine Disruptors - Senate Hearing and New Administration

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.